Ex-Olympian Shawn Johnson East Shares Son’s Harrowing RSV Experience
Olympic gold medalist gymnast Shawn Johnson East had respiratory syncytial virus-related experiences with all 3 of her ...
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for ...
Medpage Today on MSN2d
FDA Expands Approval of RSV Vaccine Abrysvo to Include All At-Risk Adults
The FDA expanded the approval of the bivalent RSV prefusion F (RSVpreF) vaccine (Abrysvo) to include the prevention of lower ...
fox13now11h
A 'gamechanger' in the fight against RSV
Important information new parents need to know about Respiratory Syncytial Virus, or RSV. It comes around when the weather ...
ENDPOINTS NEWS9h
CDC ad­vi­sors de­cline to rec­om­mend RSV shots to younger at-risk adults, af­firm­ing pri­or guid­ance
The CDC's vaccine policy advisors haven't budged on new RSV guidance, remaining unconvinced that younger adults at higher ...
US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease
The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...
Monthly Prescribing Reference8h
Arexvy Looks Promising for RSV Protection in Younger At-Risk and Immunocompromised Adults
Arexvy is currently approved for active immunization for the prevention of LRTD caused by RSV in individuals 60 years of age and older, and those 50 to 59 years of age who are at increased risk for ...
WZZM on MSN1d
Experts encourage pregnant women to get the RSV vaccine before cases begin to rise
GRAND RAPIDS, Mich. — Soon, we could see cases of respiratory syncytial virus (RSV) begin to rise in West Michigan. Which is ...
BioPharma Dive1d
Pfizer’s RSV vaccine cleared by FDA for use in some younger adults
Approval of Pfizer's Abrysvo in certain adults aged 18 to 59 years old will substantially expand the number of people ...
Study confirms RSV vaccine's protective power for seniors
A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% ...
FiercePharma1d
FDA approves Pfizer's RSV shot Abrysvo for all at-risk adults
While it’s a win for Pfizer over GSK and its RSV vaccine Arexvy, which is approved for those 50 and older, it’s difficult to ...
Merck's RSV antibody for infants effective in reducing some types of infections in study
Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...